Status:
UNKNOWN
Rehabilitation for Patients With Persistent Symptoms Post COVID-19
Lead Sponsor:
Western Norway University of Applied Sciences
Collaborating Sponsors:
Helse-Bergen HF
Conditions:
Covid19
Eligibility:
All Genders
18-67 years
Phase:
NA
Brief Summary
A large proportion of persons who have had COVID-19 have reported persisted symptoms as fatigue and dyspnea months post infection which affect activities of daily living. The aim of the study is to e...
Detailed Description
In March 2020, the World Health Organization (WHO) declared the COVID-19 outbreak to be a pandemic, and a year later more than 120 000 000 people are confirmed with the disease. The disease has caused...
Eligibility Criteria
Inclusion
- persistent symptoms minimum 2 months post COVID-19 infection
- reduced exercise capacity level
- symptoms of dyspnea and/or fatigue
Exclusion
- diseases where exercise is contraindicated (e.g. unstable angina pectoris)
- drug abuse, severe mental illness where treatment in groups are contraindicated.
Key Trial Info
Start Date :
March 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2023
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04836351
Start Date
March 1 2021
End Date
December 30 2023
Last Update
April 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Helse i Hardanger
Øystese, Kvam Herad, Norway, 5610